Showing results (891-900 of 1,479) with videos related to

Sort By:
Pageof 148
Plos One|October 29, 2014
Escherichia coli flagellar genes as target sites for integration and expression of genetic circuitsMario Juhas, Lewis D B Evans, Joe Frost, et al.
Neurology. Clinical Practice|May 10, 2021
Prolonged Ventilatory Support for Patients Recovering From Guillain-Barré SyndromeMichael C F Cheng, Patrick B Murphy, Nicholas Hart, et al.
Aging & Mental Health|June 28, 2024
Strategic and operational issues in sustaining community-based dementia support groups: the Get Real with Meeting Centres realist evaluation part 2Thomas Morton, Shirley B Evans, Ruby Swift, et al.
Public Health|June 29, 2010
The international follow-up of individuals potentially exposed to polonium-210 in London 2006K Shaw, K Anders, B Olowokure, et al.
Cancer Research|January 13, 1998
DNA adducts in human pancreatic tissues and their potential role in carcinogenesisM Wang, J L Abbruzzese, H Friess, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1981
'Nephrotoxicity' and metabolic acidosis in transplant patients on cyclosporin AD V Hamilton, D B Evans, R G Henderson, et al.
Oncogene|March 1, 2005
HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomasMichael J Gray, Jing Zhang, Lee M Ellis, et al.
Breast Cancer Research and Treatment|June 12, 2016
Preoperative breast magnetic resonance imaging and contralateral breast cancer occurrence among older women with ductal carcinoma in situShi-Yi Wang, Jessica B Long, Brigid K Killelea, et al.
Clinical Science (London, England : 1979)|June 1, 1993
Suppression of non-esterified fatty acids and triacylglycerol in experimental animals by the adenosine analogue GR79236P Strong, R Anderson, J Coates, et al.
British Journal of Cancer|April 14, 2010
EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapyA H Evans, S Pancholi, I Farmer, et al.
Pageof 148